What is Ab E Discovery?
Ab E Discovery is a company focused on providing innovative poultry health solutions. Their flagship product, Cosabody, is a patented egg yolk product designed to enhance the immune systems of animals, thereby improving production outcomes. The company's mission centers on optimizing gastrointestinal tract immunity to aid animals in managing parasites and pathogens. Cosabody is an all-natural additive introduced into animal feed, aiming to reduce mortality rates and boost overall egg production. Ab E Discovery primarily targets clients within the poultry industry, promising healthier birds and enhanced returns on investment.
How much funding has Ab E Discovery raised?
Ab E Discovery has raised a total of $323K across 2 funding rounds:
Debt
$150K
Debt
$173K
Debt (2020): $150K with participation from PPP
Debt (2021): $173K led by PPP
What's next for Ab E Discovery?
With the recent influx of capital from a large-scale, late-stage funding round, Ab E Discovery is poised for significant growth and strategic development. This investment suggests confidence from stakeholders in the company's patented technology and its market penetration strategy within the poultry health sector. Future initiatives are likely to focus on scaling production, expanding market reach, and potentially further research and development to enhance their product offerings and solidify their competitive advantage in the animal health industry.
See full Ab E Discovery company page
